ER-34122

CAS No. 179325-62-3

ER-34122( —— )

Catalog No. M36331 CAS No. 179325-62-3

ER-34122, a novel orally available dual 5-lipoxygenase/cyclooxygenase inhibitor, exhibits potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
50MG 830 In Stock
100MG 1097 In Stock
200MG 1479 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ER-34122
  • Note
    Research use only, not for human use.
  • Brief Description
    ER-34122, a novel orally available dual 5-lipoxygenase/cyclooxygenase inhibitor, exhibits potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
  • Description
    ER-34122, a novel orally available dual 5-lipoxygenase/cyclooxygenase inhibitor, exhibits potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    Lipoxygenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    179325-62-3
  • Formula Weight
    507.96
  • Molecular Formula
    C27H26ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N)C1=CC(=CC=C1Cl)C(OC)(OC)C2=NN(C3=CC=C(OC)C=C3)C(=C2)C=4C=CC(OC)=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AA-861

    AA-861 (Docebenone) is a potent, selective 5-Lipoxygenase (5-LO) inhibitor with IC50 of 0.8 uM.

  • 5-DEMETHYLNOBILETIN

    5-DEMETHYLNOBILETIN is a natual product has anti-inflammatory activity it may act through a direct inhibition of 5-LOX without affecting the expression of COX-2.

  • 12R-LOX-IN-2

    12R-LOX-IN-2 is an inhibitor of 12R-lipoxygenase (12R-LOX).12R-LOX-IN-2 inhibits imiquimod (IMQ)-induced hyperproliferation of psoriatic keratinocytes and inhibits colony formation.